ADAR1 Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.99M | Buy |
3,081,414
+3,034,378
| +6,451% | +$6.89M | 1.07% | 23 |
|
|
2025
Q1 | $29.9K | Sell |
47,036
-98,000
| -68% | -$62.3K | 0.01% | 182 |
|
|
2024
Q4 | $149K | Sell |
145,036
-758,923
| -84% | -$782K | 0.03% | 160 |
|
|
2024
Q3 | $1.07M | Buy |
903,959
+331,789
| +58% | +$392K | 0.17% | 63 |
|
|
2024
Q2 | $698K | Buy |
572,170
+417,170
| +269% | +$509K | 0.13% | 76 |
|
|
2024
Q1 | $338K | Buy |
+155,000
| New | +$338K | 0.08% | 91 |
|